There is conflicting data on PARP-1 deficiency driving Th1 differentiation of CD4+ T-cells, with one study in a model of airway inflammation observing olaparib promoting the Th1 phenotype whereas a model of inflammatory arthritis observed PARP inhibition associated with a suppression of Th-1-associated cytokines. This evidence concerns the gene PARP1 and inflammatory response.